Table 5.
Virological outcomes and drug resistance in patients who initiated zidovudine- and tenofovir-based first-line antiretroviral therapy from 2011 to 2015.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.